Gynuity Health Projects Inc

Nonprofit profile at a glance

EIN
825129481
IRS 990 coverage
2019–2024
Forms available
Form 990 2024, Form 990-N 2018
Location
New York, NY, USA
Phone
2124481230
Rating
57
Verdict
MIXED
Rating confidence
Moderate
Sector
Reproductive Health Care Facilities and Allied Services

Reported finances

Revenue
$829,790
Expenses
$935,838
Assets
$353,713
Liabilities
$278,419

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

9 people listed

Executive titles in this filing

  • BEVERLY WINIKOFF (PRESIDENT)

Highest reported compensation

  • BEVERLY WINIKOFF (PRESIDENT): $184,253 total reported compensation
  • YELENA ELYUKIN (TREASURER/SR. DIR. OF FINANCE AND ADMINISTRATION): $103,166 total reported compensation
  • JILL DUROCHER (INTERIM SECRETARY/SENIOR DIRECTOR): $75,941 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Gynuity health projects works to develop and advocate for the use of scientific, clinical and programmatic evidence in reproductive and maternal health, assuring that each individual benefits from the fruits of medical science and technology.

What it reported doing in 2024

Gynuity health projects is at the frontline of global research and advocacy efforts to expand access to medication abortion and improve the management of obstetric complications. In 2024, we organized a technical meeting of organizations engaged in medication abortion service delivery, advocacy, and research. Building on key learnings from our proof-of-concept study in mexico evaluating use of ulipristal acetate (upa) as an alternative to mifepristone for medication abortion, we initiated new research to further establish the utility of upa in a combined regimen with misoprostol. Enrollment began for a study evaluating the feasibility of medication abortion services via telemedicine using misoprostol alone in ecuador and for a study in mexico exploring a new 'period pills' regimen used to regulate menstruation without prior pregnancy confirmation. This year, we published several new journal articles summarizing completed studies, including one in the united states testing a new online program to determine eligibility for medication abortion that uses a self-completed questionnaire, and another conducted in public sector facilities in nepal evaluating the potential of an outpatient model to limit inpatient care and overnight stays for second trimester (13-18 weeks) medication induction. At gynuity, we perform research on promising maternal health technologies and models of care suitable for use in low-resource environments. In 2024, we published the clinical results from a randomized trial undertaken in central india confirming oral misoprostol alone as an effective option for inducing labor in pregnancies complicated by hypertension. We continued to engage strategically with partners and leading health authorities to share evidence for updating guidelines and practices.

Operating model

Revenue model
Donor-supported. 99% of the money available for current operations came from contributions and gifts.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

MIXED - Most voting board members are independent. A relatively small share of total spending goes to programs and the filing reports few safeguards for money sent abroad.

Rating breakdown

  • Financial Efficiency: 57
  • Transparency & Controls: 54
  • Accountability: 79
  • Sustainability: 13
  • Growth: 40

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 60.2%; rating input score 60
  • Program expense ratio: 53.1%; rating input score 53
  • Fundraising efficiency: $17.19 raised per $1 spent on fundraising; rating input score 54; 54th percentile among comparable filings

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 3 of 6 controls in place; rating input score 50
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Pass
    • Written employment contract: Missing
    • Compensation survey or study: Pass
    • Board or committee approval: Pass
  • Foreign activity oversight: Scored; rating input score 0
  • Grant itemization coverage: Scored; rating input score 0
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 80%; rating input score 80; 18th percentile among comparable filings
  • Governance controls: 7 of 9 controls in place; rating input score 78
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Fail
    • CEO compensation review process: Pass
    • Other executive compensation review process: Pass
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: -12.8%; rating input score 14; 14th percentile among comparable filings
  • Total-asset coverage ratio: 0.38; rating input score 18; 18th percentile among comparable filings
  • Liabilities to assets ratio: 0.79; rating input score 9; 9th percentile among comparable filings
  • Officer compensation ratio: 38.8%; rating input score 4; 4th percentile among comparable filings

Growth

  • Program expense growth: 3.6% per year; rating input score 100; 35th percentile among comparable filings
  • Revenue growth: -21.8% per year; rating input score 0; 1st percentile among comparable filings
  • Asset growth: -28.7% per year; rating input score 0; 1st percentile among comparable filings

Details

  • Where the money goes: 60.2% of revenue deployed · 53.1% of spending went to programs
  • Governance: 4 of 5 board members independent · 7 of 9 filing controls reported
  • Programs: 1 filed program accomplishment · $496K in reported program spending
  • Leadership: top reported pay $184K · 9 people listed · 3 of 6 pay-setting controls reported
  • Consistency: 27 of 27 current checks pass
  • Schedules: 6 filed schedules · includes major donors, foreign activity, and executive pay
  • Filing history: 5 filing years from 2019 to 2024
  • Contacts: How to reach this organization
  • Money network: 3 filed money-flow records
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.
  • Staff and benefit plans: Retirement and health plans the organization files with the Department of Labor, and the people in them.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Financial Efficiency: Program expense ratio scored 53/100.
  • High — Transparency & Controls: Foreign activity oversight scored 0/100.
  • High — Transparency & Controls: Grant itemization coverage scored 0/100.
  • Review — Financial Efficiency: Fundraising efficiency scored 54/100.
  • High — Sustainability: Operating margin scored 14/100.
  • High — Growth: Revenue growth scored 0/100.
  • Review — Accountability: Governance controls: 2 of 9 not reported.
  • High — Sustainability: Total-asset coverage ratio scored 18/100.
  • High — Growth: Asset growth scored 0/100.
  • High — Sustainability: Officer compensation ratio scored 4/100.
  • High — Sustainability: Liabilities to assets ratio scored 9/100.